Myeloproliferative Neoplasm [Hot Topic]

  Рет қаралды 11,285

Mayo Clinic Laboratories

Mayo Clinic Laboratories

Күн бұрын

Myeloproliferative neoplasm (MPN) is a malignancy of hematopoietic stem cells that is associated with hematopoietic proliferation resulting in peripheral blood cytosis. MPN is subclassified on the basis of the dominant cell line involved and each subtype has a different prognosis. The diagnosis of MPN must include an integrated approach and combine the clinical findings with laboratory results. Dr. He discusses the subclassification of MPNs and the use of JAK2, CALR, and MPL mutational analysis in diagnosis and prognosis.
A presentation by Rong He, MD

Пікірлер
Why MPNs Transform to AML
23:38
HMP Education
Рет қаралды 2,2 М.
iPhone or Chocolate??
00:16
Hungry FAM
Рет қаралды 43 МЛН
小天使和小丑太会演了!#小丑#天使#家庭#搞笑
00:25
家庭搞笑日记
Рет қаралды 31 МЛН
Running With Bigger And Bigger Lunchlys
00:18
MrBeast
Рет қаралды 117 МЛН
Anti-Xa Assay for Heparin Monitoring [Hot Topic]
26:02
Mayo Clinic Laboratories
Рет қаралды 17 М.
Myeloproliferative Disorders - CRASH! Medical Review Series
12:44
Paul Bolin, M.D.
Рет қаралды 4,8 М.
Ask the Expert: Polycythemia Vera
30:17
OMNIConnect
Рет қаралды 26 М.
Monoclonal Gammopathy of Undetermined Significance (MGUS) [Hot Topic]
21:46
Mayo Clinic Laboratories
Рет қаралды 18 М.
JAK2 V617F VAF as a diagnostic and prognostic marker for polycythemia vera and thrombosis risk
7:03
VJHemOnc – Video Journal of Hematology & HemOnc
Рет қаралды 9 М.
Current Management of Polycythemia Vera - Richard T. Silver, MD
32:34
Cancer Research & Treatment Fund
Рет қаралды 8 М.
Living with A Rare Blood Cancer, Polycythemia Vera
19:41
Access Health
Рет қаралды 134 М.
Mutations in Myelofibrosis: Which to Test for, When and Why
23:17
HMP Education
Рет қаралды 4,4 М.